FFCP PHASE2:Hg19::chr11:28129656..28129735,-
From FANTOM5_SSTAR
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search
Short description: | p1@KIF18A |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_1_at_KIF18A_5end |
Coexpression cluster: | C109_Reticulocytes_non_acute_Hodgkin_Burkitt_retinoblastoma_lymphoma |
Association with transcript: | 0bp_to_ENST00000263181, ENST00000526288_5end |
EntrezGene: | KIF18A |
HGNC: | 29441 |
UniProt: | Q8NI77 |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
Sample | p1@KIF18A |
---|
0
10
20
30
40
50
60
70
80
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
cancer | 2.55e-53 | 235 |
disease of cellular proliferation | 1.15e-52 | 239 |
cell type cancer | 2.80e-28 | 143 |
organ system cancer | 2.27e-24 | 137 |
carcinoma | 2.92e-21 | 106 |
hematologic cancer | 2.89e-16 | 51 |
immune system cancer | 2.89e-16 | 51 |
leukemia | 3.62e-12 | 39 |
myeloid leukemia | 6.01e-09 | 31 |
disease of anatomical entity | 5.14e-07 | 39 |
Showing 1 to 10 of 10 entries